B Petrini

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. ncbi Non-tuberculous mycobacterial infections
    Bjorn Petrini
    Clinical Microbiology, Karolinska University Laboratory, Solna, Stockholm, Sweden
    Scand J Infect Dis 38:246-55. 2006
  2. ncbi Mycobacterium marinum: ubiquitous agent of waterborne granulomatous skin infections
    B Petrini
    Department of Clinical Microbiology, Karolinska University Hospital Solna and Karolinska Institutet, 17176, Stockholm, Sweden
    Eur J Clin Microbiol Infect Dis 25:609-13. 2006
  3. ncbi Concomitant late soft tissue infections by Cladophialophora bantiana and Mycobacterium abscessus following tsunami injuries
    Bjorn Petrini
    Departments of Clinical Microbiology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden
    Med Mycol 44:189-92. 2006
  4. ncbi [National contact tracing of tuberculosis should be introduced]
    Bjorn Petrini
    Sektionen för mykobakteriologi, Avdelningen för klinisk mikrobiologi, Karolinska Universitetssjukhuset, Solna
    Lakartidningen 102:977. 2005
  5. ncbi Mycobacterium abscessus: an emerging rapid-growing potential pathogen
    Bjorn Petrini
    Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
    APMIS 114:319-28. 2006
  6. ncbi [BCG vaccination--controversy and compromise]
    B Petrini
    Avdelningen för klinisk mikrobiologi, Karolinska institutet och Karolinska sjukhuset, Stockholm
    Lakartidningen 97:5618-20. 2000
  7. ncbi Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis
    U Forslöw
    Division of Respiratory Medicine and Allergology, Department of Medicine, Stockholm CF Centre, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
    Acta Paediatr 92:910-5. 2003
  8. ncbi Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden
    B Kan
    Infectious Diseases Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden
    Int J Tuberc Lung Dis 12:199-204. 2008
  9. ncbi Malassezia pachydermatis fungaemia in a neonatal intensive care unit
    E Chryssanthou
    Department of Clinical Microbiology, Karolinska Institute and Hospital, Stockholm, Sweden
    Acta Paediatr 90:323-7. 2001
  10. ncbi Drug-resistant and multidrug-resistant tubercle bacilli
    B Petrini
    Department of Clinical Microbiology, Karolinska Institute and Hospital, Stockholm, Sweden
    Int J Antimicrob Agents 13:93-7. 1999

Detail Information

Publications14

  1. ncbi Non-tuberculous mycobacterial infections
    Bjorn Petrini
    Clinical Microbiology, Karolinska University Laboratory, Solna, Stockholm, Sweden
    Scand J Infect Dis 38:246-55. 2006
    ..The spectrum of disease caused by NTM species that display a very low pathogenic potential is likely to widen over time as severe immunosuppression will continue to be prevalent in several patient categories...
  2. ncbi Mycobacterium marinum: ubiquitous agent of waterborne granulomatous skin infections
    B Petrini
    Department of Clinical Microbiology, Karolinska University Hospital Solna and Karolinska Institutet, 17176, Stockholm, Sweden
    Eur J Clin Microbiol Infect Dis 25:609-13. 2006
    ..Doxycycline or clarithromycin is used most commonly, although in severe cases, a combination of rifampicin and ethambutol is recommended...
  3. ncbi Concomitant late soft tissue infections by Cladophialophora bantiana and Mycobacterium abscessus following tsunami injuries
    Bjorn Petrini
    Departments of Clinical Microbiology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden
    Med Mycol 44:189-92. 2006
    ..The symptoms gradually subsided in the male patient, but recurrent abscesses were noted with the female patient, from which M. abscessus was recovered despite prolonged antibiotic therapy...
  4. ncbi [National contact tracing of tuberculosis should be introduced]
    Bjorn Petrini
    Sektionen för mykobakteriologi, Avdelningen för klinisk mikrobiologi, Karolinska Universitetssjukhuset, Solna
    Lakartidningen 102:977. 2005
  5. ncbi Mycobacterium abscessus: an emerging rapid-growing potential pathogen
    Bjorn Petrini
    Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
    APMIS 114:319-28. 2006
    ..abscessus infection, and if conducted, it should include the removal of all foreign or necrotic material. There is increasing awareness of M. abscessus as an emerging pathogen...
  6. ncbi [BCG vaccination--controversy and compromise]
    B Petrini
    Avdelningen för klinisk mikrobiologi, Karolinska institutet och Karolinska sjukhuset, Stockholm
    Lakartidningen 97:5618-20. 2000
    ..If large numbers of refugees from high-endemic countries arrive in Sweden, the epidemiological situation must be closely monitored...
  7. ncbi Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis
    U Forslöw
    Division of Respiratory Medicine and Allergology, Department of Medicine, Stockholm CF Centre, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
    Acta Paediatr 92:910-5. 2003
    ..To evaluate the response rate to antimycobacterial drug therapy in patients with cystic fibrosis (CF) suffering from infection by non-tuberculous mycobacteria (NTM)...
  8. ncbi Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden
    B Kan
    Infectious Diseases Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden
    Int J Tuberc Lung Dis 12:199-204. 2008
    ..City of Stockholm, Sweden...
  9. ncbi Malassezia pachydermatis fungaemia in a neonatal intensive care unit
    E Chryssanthou
    Department of Clinical Microbiology, Karolinska Institute and Hospital, Stockholm, Sweden
    Acta Paediatr 90:323-7. 2001
    ..Since no epidemiological association among the strains could be shown, the reason for this cluster of nosocomial fungaemias remains unclear...
  10. ncbi Drug-resistant and multidrug-resistant tubercle bacilli
    B Petrini
    Department of Clinical Microbiology, Karolinska Institute and Hospital, Stockholm, Sweden
    Int J Antimicrob Agents 13:93-7. 1999
    ..In this review some aspects of epidemiology, diagnosis and mechanisms of DR in TB are discussed. MDR-TB is an important international problem of increasing significance for the whole global community...
  11. ncbi Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia
    M Bjorkholm
    Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    Scand J Infect Dis 33:316-9. 2001
    ..Early diagnostic procedures combined with high doses of liposomal amphotericin B and surgical resection may have contributed to the successful outcome...
  12. pmc Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse
    E Rylander
    Division of Obstetrics and Gynaecology, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
    Sex Transm Infect 80:54-7. 2004
    ..To study the prevalence of vulvovaginal candida among sexually active adolescents. To determine past and present symptoms, including pain at intercourse and potential behavioural risk factors associated with vulvovaginal candidiasis...
  13. ncbi PCR and other non-culture methods for diagnosis of invasive Candida infections in allogeneic bone marrow and solid organ transplant recipients
    E Chryssanthou
    Department of Laboratory Medicine, Karolinska Institute and Hospital, Stockholm, Sweden
    Mycoses 42:239-47. 1999
    ..Combination of several non-culture assays is needed to diagnose invasive fungal infection in high-risk transplant recipients. No single test was sufficient for diagnosis...
  14. ncbi Complicated course of local mycobacterial infection in an immunocompetent girl
    B Lundberg
    Department of Otorhinolaryngology, Danderyd s Hospital, Stockholm, Sweden
    Scand J Infect Dis 28:99-100. 1996
    ..Surgery was not judged possible but chemotherapy was given for 6 months during which the infection healed. It is not clear whether the regression was spontaneous or caused by the therapy...